Pyxis Oncology names Thomas Civik permanent CEO and board chair
Go back to Pyxis Oncology names Thomas Civik permanent CEO and board chair| (NASDAQ: PYXS) | Delayed: 3.27 -0.11 (3.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.38 | 52 Week High | $ | |||
| Open | $3.42 | 52 Week Low | $ | |||
| Day High | $3.44 | P/E | N/A | |||
| Day Low | $3.18 | EPS | $ | |||
| Volume | 739,135 | |||||

